Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation (NCT07639255)
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS System
🩺 Plain-English Summary (8th-Grade Level)
This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements associated with improved quality and retention of patients in the screening process. A feedback report is delivered to identify priorities for process improvement.
Who can join: Review the eligibility criteria below.
Location: King's Daughter's Medical Center — Ashland, Kentucky
Age range: 18 Years to 100 Years
🧪 Interventions in This Study
- QUILS System (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (17 Sites)
- King's Daughter's Medical Center — Ashland, Kentucky
- Taylor Regional Hospital — Campbellsville, Kentucky
- St. Elizabeth Healthcare — Edgewood, Kentucky
- Georgetown Cancer Treatment Cancer — Georgetown, Kentucky
- TJ Samson Community Hospital — Glasgow, Kentucky
- Hazard Appalachian Regional Healthcare Medical Center — Hazard, Kentucky
- Lexington VA Health Care System — Lexington, Kentucky
- St. Joseph Health (Catholic Health Initiatives) — Lexington, Kentucky
- University of Kentucky Markey Cancer Center — Lexington, Kentucky
- The James Graham Brown Cancer Center at University of Louisville — Louisville, Kentucky
- Meadowview Regional Medical Center — Maysville, Kentucky
- Saint Claire Regional Medical Center — Morehead, Kentucky
- Rockcastle Regional Hospital — Mount Vernon, Kentucky
- Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky
- Mercy Health - Paducah Cancer Center — Paducah, Kentucky
- Lake Cumberland Regional Hospital — Somerset, Kentucky
- Clark Regional Medical Center — Winchester, Kentucky
📞 Contact the Study Coordinator
Phone: (859) 323-0892
Email: joseph.alexander@uky.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Cancer Screening
- Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+) — Anaheim, California
- Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM) — Bogotá,
- LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI) — Chicago, Illinois
- A Study of Lung Cancer Screening in People With Unexplained Weight Loss — Basking Ridge, New Jersey
- Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans — New Orleans, Louisiana
Explore by condition: All Lung Cancer Screening clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.